JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on December 19, 2006; DOI: 10.1124/jpet.106.114835


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.106.114835v1
320/3/1106    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Salim, S.
Right arrow Articles by Eikenburg, D. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Salim, S.
Right arrow Articles by Eikenburg, D. C.


Received for publication October 2, 2006.
Revised December 16, 2006.
Accepted for publication December 18, 2006.

Role of Hsp90 and Protein Degradation in Regulating Neuronal Levels of GRK3

Samina Salim 1 Douglas C. Eikenburg 1*

1 University of Houston

* Address correspondence to: E-mail: deikenburg{at}uh.edu

Abstract

Cellular levels of GRK3 determine the sensitivity of the alpha2A/B-adrenoceptor ({alpha}2-AR) to agonist-induced down-regulation. Using human neuroblastoma BE(2)-C cells, this study examines how cellular GRK3 levels are affected by several mechanisms reported to influence stability and degradation of other GRKs. We first examined the interaction between the heat shock protein 90 (Hsp90) and GRK3; Hsp90 reportedly affects the maturation and stability of GRK2. In unstimulated cells, GRK3 co-immunoprecipitates (Co-IP) with Hsp90, suggesting a physical interaction. Moreover, when GRK3 protein expression was increased by 24h epinephrine (EPI) treatment, Hsp90 protein expression increased with a similar but slightly delayed time course. To investigate the influence of Hsp90 on GRK3 protein stability, we determined the effect of the Hsp90 inhibitor, geldanamycin (GA) on cellular GRK3 levels. GA eliminated the interaction between Hsp90 with GRK3 and produced a rapid, proteosome-mediated, 70% decrease in GRK3 levels within 24h. To investigate the influence of Hsp90 on up-regulation of GRK3 expression, we examined the effect of GA on EPI-induced up-regulation. GA reduced the absolute increase in GRK3; however, the percent increase in GRK3 by EPI was not significantly different in the absence vs. presence of GA (141±41% vs. 94±12%). Finally, we examined the influence of Ca+2-activated proteases on cellular GRK3. Treatment with the calcium ionophore, ionomycin produced a rapid decrease in GRK3 levels that was inhibited by the calpain inhibitor, calpeptin. In conclusion, several mechanisms influence the degradation of GRK3, and therefore have the potential to affect GPCR signaling by regulating GRK3 levels in neurons.


Key words: GRK3, Heat Shock Protein, calpain, degradation, neuron, proteosome





Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics.